Related Experiment Videos
HIV-induced T-lymphocyte depletion
1Department of Medicine, New York Hospital-Cornell Medical Center, New York.
Clinics in Laboratory Medicine
|June 1, 1994
Summary
Human immunodeficiency virus (HIV) causes progressive CD4+ T-cell loss through diverse mechanisms, including immune destruction and viral effects. Understanding these processes is key to managing HIV disease progression.
Area of Science:
- Immunology
- Virology
- Cell Biology
Background:
- A key paradox in human immunodeficiency virus (HIV) disease is the significant loss of CD4+ lymphocytes, even when only a small percentage of cells are infected.
- The precise mechanisms driving T-cell depletion in HIV infection remain incompletely understood, posing a challenge for therapeutic strategies.
Purpose of the Study:
- To review the multifaceted mechanisms responsible for CD4+ T-cell depletion in the context of HIV disease.
- To elucidate how various cellular and viral factors contribute to immunodeficiency progression during HIV infection.
Main Methods:
- Literature review of existing research on HIV pathogenesis and T-cell dynamics.
- Analysis of mechanisms including immune-mediated destruction, autoimmune responses, and direct viral cytotoxicity.
- Examination of signaling pathway disruptions leading to T-cell anergy and apoptosis.
Main Results:
- HIV infection triggers a complex interplay of immune-mediated and autoimmune destruction targeting both infected and uninfected CD4+ T-cells.
- Viral particles and proteins exert direct cytotoxic effects, contributing to T-cell loss.
- Disruptions in cellular signaling pathways induce T-cell anergy and programmed cell death (apoptosis).
Conclusions:
- T-cell depletion in HIV disease is multifactorial, involving immune surveillance, autoimmune reactions, and direct viral impact.
- These mechanisms contribute to the progressive decline of CD4+ T-cells across different clinical stages of HIV infection.
- A comprehensive understanding of these diverse pathways is crucial for developing effective interventions against HIV-induced immunodeficiency.